logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울행정법원 2019.11.12 2019구합51604
특정물질수입허가및판매계획승인불가처분취소
Text

1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

Reasons

. For the smooth reduction of specific substances: (a) restrictions are placed on cases where alternative substances are manufactured or imported (standard quantities) in 2009 and 2010; (b) restrictions are placed on the use of alternative substances; (c) restrictions are placed on the license of new manufacturers by many countries, such as the EU and Australia, within the standard limits on a yearly basis; and (d) permission is granted to only those manufacturers with the standard quantities at the time of the first reduction; and (b) where there are no applications for the manufacture or import and import of specific substances for two consecutive years even if the standard quantities exist, they are excluded from those subject to the license; and (b) the manufacturing and import license of specific substances; and (c) the volume of sales plan is calculated by applying the annual reduction rate for the number of the previous year of the applicants for the license - the manufacturing and import license of specific substances for 2013 and the volume of sales plan is determined on the basis of the base quantity for each permitted person; and (b) the content of specific substances is determined on the basis of the 20-C average quantity of specific substances to be determined by 20%.

The instant public notice is an annual production and consumption by year from 2013 to 2030, calculated by applying the annual average reduction rate calculated on the basis of the threshold for production and consumption of specific substances in 2013, 2015, 2020, 2025, and 2030 under the Protocol.

arrow